Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
06/1995
06/06/1995CA1335789C Fatty acid compositions
06/01/1995WO1995014697A1 Heterocyclic esters of rapamycin and pharmaceutical compositions containing them
06/01/1995WO1995014696A1 Hindered esters of rapamycin and their use as pharmaceuticals
06/01/1995WO1995014683A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
06/01/1995WO1995014681A1 Isoxazoline compounds as antiinflammatory agents
06/01/1995WO1995014680A1 3-aryl-2-isoxazolines as antiinflammatory agents
06/01/1995WO1995014669A1 Novel benzenesulfonylimine derivatives as inhibitors of il-1 action
06/01/1995WO1995014667A1 Substituted indoles as phosphodiesterase type iv inhibitors
06/01/1995WO1995014666A1 Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s)
06/01/1995WO1995014464A1 Ssi tyrphostins and pharmaceutical compositions
06/01/1995CA2224051A1 Intermediates for producing substituted indoles as phosphodiesterase type iv inhibitors
06/01/1995CA2224049A1 Intermediates for producing substituted indoles as phosphodiesterase type iv inhibitors
06/01/1995CA2177375A1 3-aryl-2-isoxazolines as antiinflammatory agents
06/01/1995CA2177289A1 Ssi tyrphostins and pharmaceutical compositions
06/01/1995CA2176961A1 Heterocyclic esters of rapamycin and pharmaceutical compositions containing them
06/01/1995CA2176955A1 Hindered esters of rapamycin and their use as pharmaceuticals
06/01/1995CA2176140A1 Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s)
06/01/1995CA2174838A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
05/1995
05/31/1995EP0655460A1 Pharmacotherapeutical use of glutathione derivatives
05/31/1995EP0655442A1 Piperazine derivatives as Tachykinin antagonists
05/31/1995EP0655055A1 Tachykinin antagonists
05/31/1995EP0654994A1 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators
05/31/1995EP0654973A1 System of drug delivery to the lymphatic tissues
05/31/1995CN1028655C NF-1616-904 oxide of pyrazine and medicine composition contained this compound
05/31/1995CN1028639C Improvements in and relating to leukotriene antagonists
05/31/1995CA2137025A1 Liquid preparations containing cyclosporin and process for preparing same
05/30/1995US5420298 Pyrrolidine derivatives
05/30/1995US5420158 Melatonin activity
05/30/1995US5420154 Administering a 2-pyrrolidinone derivative to an animal suffering from a tumor necrosis factor mediated disease
05/30/1995US5420143 Piperidine derivatives for treating allergy
05/30/1995US5420131 Platelet activating factor antagonist or 5-lipoxygenase inhibitors
05/30/1995US5420109 Cytokine restraining agents
05/30/1995US5419900 Autoimmune disease
05/30/1995US5419898 Antiallergic composition for ophthalmic or nasal use
05/30/1995CA2136712A1 Piperazine derivatives
05/26/1995WO1995014082A1 Delivery of gene products via mesangial cells
05/26/1995WO1995014026A1 Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use
05/26/1995WO1995014023A1 Semisynthetic analogs of rapamycin (macrolides) being immunomodulators
05/26/1995WO1995014016A1 Prodrugs of an inhibitor of hiv protease
05/26/1995WO1995014007A1 Phenyl-alkyl imidazoles as h3-receptor antagonists
05/26/1995WO1995013826A1 Preventive and remedy for allergic disease
05/26/1995WO1995013823A1 Method of treating neurological disorders
05/26/1995WO1995013820A1 Use of an agent which modulates tyrosine phosphorylation for modulating the permeability of a psychological barrier
05/26/1995WO1995013805A1 Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases
05/26/1995WO1995013803A1 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
05/26/1995WO1995013797A1 Interdigitation-fusion liposomes containing arachidonic acid metabolites
05/26/1995CA2176747A1 Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases
05/26/1995CA2176708A1 Method of treating neurological disorders
05/26/1995CA2176143A1 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
05/26/1995CA2175350A1 Interdigitation-fusion liposomes containing arachidonic acid metabolites
05/26/1995CA2174649A1 Prodrugs of an inhibitor of hiv protease
05/26/1995CA2153482A1 Delivery of gene products via mesangial cells
05/24/1995EP0654037A1 Antiretroviral enantiomeric nucleotide analogs
05/24/1995EP0548194B1 Monoclonal antibody active against the interleukin-2 receptor
05/24/1995EP0417254B1 Production of beta-1,3-glucan in algae
05/23/1995CA1335653C Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
05/18/1995WO1995013370A1 Haemophilus transferrin receptor genes
05/18/1995WO1995013295A1 Human monocyte chemoattractant protein-1 (mcp-1) derivatives
05/18/1995WO1995013294A1 Cytokines from natural killer or t cells
05/18/1995WO1995013289A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
05/18/1995WO1995013277A1 6-oxo-nucleosides useful as immunosuppressants
05/18/1995WO1995013090A1 Improved interferon polymer conjugates
05/18/1995WO1995013089A1 Compositions and method for stimulating antibody release by b lymphocytes
05/18/1995WO1995013086A1 Cytokine restraining agents
05/18/1995WO1995013071A2 Treatment of immunoregulatory disorders
05/18/1995WO1995013067A1 Oxazoles for treating cytokine mediated diseases
05/18/1995WO1995013064A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists
05/18/1995CA2176217A1 Human monocyte chemoattractant protein-1 (mcp-1) derivatives
05/18/1995CA2176124A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists
05/18/1995CA2176115A1 Compositions and method for stimulating antibody release by b lymphocytes
05/18/1995CA2176114A1 Cytokines from natural killer or t cells
05/18/1995CA2176013A1 Treatment of immunoregulatory disorders
05/18/1995CA2175897A1 6-oxo-nucleosides useful as immunosuppressants
05/18/1995CA2173470A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
05/17/1995EP0653434A1 Glucosamine derivative, process for preparing the same and synthetic intermediate thereof
05/17/1995EP0652943A1 Hematopoietic facilitatory cells and their uses
05/17/1995EP0652896A1 Peptide compounds
05/17/1995EP0652893A1 Kininogenase inhibitors
05/17/1995EP0652891A1 T-cell membrane inducing factors
05/17/1995EP0652874A1 2-heterocyclic-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
05/17/1995EP0652864A1 Hydroxamic acid derivatives and their use as anti-inflammatory compounds
05/17/1995EP0652863A1 Non-peptidic surrogates of the ldv sequence and their use in the treatment of inflammation, autoimmune diseases and tumour progression
05/17/1995EP0652768A1 Preparation for activation of natural killer cells (nk-cells), said preparation containing interferon-alpha and histamine, serotonin or substances with corresponding receptor activity
05/17/1995EP0652764A1 Use of synthetic peptides to induce tolerance to pathogenic t and b cell epitopes of autoantigens
05/16/1995US5416202 Such as gelonin, cysteine substitution
05/16/1995US5416194 Extracted from horseshoe crab
05/16/1995US5416117 Cyclopropenone derivatives
05/16/1995US5416113 Bronchodilators
05/16/1995US5416098 Antiallergens
05/16/1995US5416087 Bis-benzo, cyclohepta piperidylidene, piperidine and piperazine compounds, compositions and methods of use
05/16/1995US5416070 Composition for macrophage activation
05/16/1995CA1335592C Pyrroloquinoline and pyrrolophenothiazine carboxamides and related compounds
05/16/1995CA1335579C Beta-d-glucan, and its production and uses
05/16/1995CA1335571C Vaccine preparation comprising a bacterial toxin adjuvant
05/13/1995CA2135536A1 Glucosamine derivative, process for preparing the same and synthetic intermediate thereof
05/11/1995WO1995012677A2 Immunodominant human t-cell epitopes of hepatitis c virus
05/11/1995WO1995012673A1 Receptor on the surface of activated t-cells: acts-4
05/11/1995WO1995012589A1 Process for the preparation of n-4-[(substituted phenyl)alkylthienyl]-, and n-4-[(substituted phenyl)alkylfuryl]but-3-yn-2-yl]-n-hydroxyurea compounds
05/11/1995WO1995012581A1 Pseudodipeptide product having an imidazole grouping and applications
05/11/1995WO1995012396A1 Method for inhibiting intracellular viral replication
1 ... 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 ... 1172